𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Simultaneous determination of blonanserin and its metabolite in human plasma and urine by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study

✍ Scribed by Yu-Guan Wen; Xiao-Jia Ni; Ming Zhang; Xia Liu; De-wei Shang

Book ID
119289217
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
812 KB
Volume
903
Category
Article
ISSN
1873-376X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simultaneous determination of udenafil a
Simultaneous determination of udenafil and its active metabolite, DA-8164, in human plasma and urine using ultra-performance liquid chromatography–tandem mass spectrometry: application to a pharmacokinetic study
✍ Soo Kyung Bae; Min Jeong Kang; Chang-Woo Yeo; Min-Jung Kim; Ji-Hong Shon; Kwang- 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

## Abstract A rapid, sensitive, and simple ultra‐performance liquid chromatography–tandem mass spectrometry (UPLC/MS/MS) method for the determination of udenafil and its active metabolite, DA‐8164, in human plasma and urine using sildenafil as an internal standard (IS) was developed and validated.

Simultaneous determination of apatinib a
Simultaneous determination of apatinib and its four major metabolites in human plasma using liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study
✍ Juefang Ding; Xiaoyan Chen; Xiaojian Dai; Dafang Zhong 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 754 KB

Apatinib, also known as YN968D1, is a novel antiangiogenic agent that selectively inhibits vascular endothelial growth factor receptor-2. Currently, apatinib is undergoing phase II/III clinical trials in China for the treatment of solid tumors. Apatinib is extensively metabolized in humans, and its